Publications by authors named "Alshaimaa M Selim"
Article Synopsis
- Intravenous polyvalent immunoglobulins (IVIG) are vital for patients with primary immunodeficiency disorders (PIDs) but access can be limited in lower middle-income countries; the WHO suggests local production using new technologies.
- A clinical study compared the safety and effectiveness of mini-pool IVIG (MP-IVIG) to standard IVIG (STD-IVIG) in 21 pediatric PID patients, finding that both treatments reduced severe bacterial infections and hospitalizations.
- Results showed that MP-IVIG did not present safety issues and was as effective as STD-IVIG, although findings should be interpreted cautiously due to the small sample size.
